Professor Stan Kaye
Cancer Research UK Professor of Medical Oncology & Head of Division of Clinical Studies, The Royal Marsden NHS Foundation Trust
Professor Stan Kaye qualified in 1972, and trained in medicine and oncology in London and Australia. He succeeded Professor Ken Calman as Head of the Department of Medical Oncology in Glasgow in the 1980’s. He built up the Department and established basic scientific research – initially in a former nunnery! He established a large Clinical Trials Unit and focussed on New Drug Development, becoming Chair of the EORTC Early Clinical Development Group. His clinical focus in Glasgow was in early phase clinical trials and the management of testicular tumours and gynaecological malignancies. Throughout his time in Glasgow he was successful in attracting programme funding from the CRC (now CRUK) and many other bodies.
He joined The Royal Marsden Hospital in September 2000 after 20 years at Glasgow University as Head of the Department of Medical Oncology. His current interests, apart from new drug development, are in ovarian cancer and drug resistance.
Professor Kaye retires as head of the Division of Clinical Studies at the Institute of Cancer Research, London this month. Until recently he was Head of the Drug Development Unit at The Royal Marsden Hospital, one of the largest Phase I trials units in the world. He has many years of experience in leading on clinical trials in cancer and has most recently been involved in the development of PARP inhibitors.
The author of over 400 peer reviewed papers, he sits on the editorial board of 12 cancer journals, and over the past 20 years has chaired national and international committees within EORTC, MRC and CRUK.
He will continue to work at the Royal Marsden Hospital in an advisory role with other commitments in Glasgow and Singapore.